Biolevate

Biolevate is a pioneering health-tech company founded in Paris in 2023, where artificial-intelligence meets life science to transform how therapeutic innovations are developed and brought to market. By combining domain-expertise in biotechnology with advanced AI tools such as natural language processing, graph neural networks and computer vision, Biolevate empowers pharmaceutical, MedTech and biotech organisations to streamline medical writing, accelerate drug discovery and ensure regulatory compliance more efficiently. The company’s mission is rooted in making cutting-edge therapies accessible faster and with greater precision, while maintaining ethical standards, data security and collaboration at the heart of its operations. With its intelligent platform and team of AI and life-science experts, Biolevate stands ready to support clients globally to reduce time-to-market, transform complex data into actionable insights and lead the next wave of healthcare innovation.